Mycosis Fungoides Therapeutics Market 2027 By Type, Distribution Channel | The Insight Partners

Mycosis Fungoides Therapeutics Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Type (Small Molecules, Biologics); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Others)

Report Code: TIPRE00016770 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming
Covid
MARKET INTRODUCTION

Mycosis fungoides is a rare form of T-cell lymphoma of the skin (cutaneous); the disease is typically slowly progressive and chronic. In individuals with mycosis fungoides, the skin becomes infiltrated with plaques and nodules that are composed of lymphocytes. In advanced cases, ulcerated tumors and infiltration of lymph nodes by diseased cells may occur. The disorder may spread to other parts of the body including the gastrointestinal system, liver, spleen, or brain.

MARKET DYNAMICS

The mycosis fungoides therapeutics market is driving due to increase in prevalence and incidence of mycosis fungoides and new drug approvals. However, stringent regulatory policies might hamper the market growth in the review period.

MARKET SCOPE

The "Mycosis Fungoides Therapeutics Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of mycosis fungoides therapeutics market with detailed market segmentation by type, and distribution channel. The mycosis fungoides therapeutics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in mycosis fungoides therapeutics market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The mycosis fungoides therapeutics market is segmented on the basis of type, and distribution channel. On the basis of type, the market is segmented into small molecules and biologics. On the basis of distribution channel, the market is segmented into hospital pharmacies, retail pharmacies and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Mycosis Fungoides Therapeutics market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Mycosis Fungoides Therapeutics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Mycosis Fungoides Therapeutics market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Mycosis Fungoides Therapeutics market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the mycosis fungoides therapeutics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from mycosis fungoides therapeutics market are anticipated to have lucrative growth opportunities in the future with the rising demand for mycosis fungoides therapeutics market in the global market. Below mentioned is the list of few companies engaged in the mycosis fungoides therapeutics market.

The report also includes the profiles of key players in mycosis fungoides therapeutics market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  Azurity Pharmaceuticals, Inc.
  •  Takeda Pharmaceutical Company Limited
  •  Soligenix
  •  Seattle Genetics, Inc.
  •  Merck & Co., Inc.
  •  Kyowa Kirin Co., Ltd.
  •  Horizon Therapeutics plc
  •  Helsinn Healthcare SA
  •  Eisai Co., Ltd.
  •  CELGENE CORPORATION

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Mycosis Fungoides Therapeutics Market - By Type
1.3.2 Mycosis Fungoides Therapeutics Market - By Distribution Channel
1.3.3 Mycosis Fungoides Therapeutics Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. MYCOSIS FUNGOIDES THERAPEUTICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. MYCOSIS FUNGOIDES THERAPEUTICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. MYCOSIS FUNGOIDES THERAPEUTICS MARKET - GLOBAL MARKET ANALYSIS
6.1. MYCOSIS FUNGOIDES THERAPEUTICS - GLOBAL MARKET OVERVIEW
6.2. MYCOSIS FUNGOIDES THERAPEUTICS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. MYCOSIS FUNGOIDES THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. SMALL MOLECULES
7.3.1. Overview
7.3.2. Small Molecules Market Forecast and Analysis
7.4. BIOLOGICS
7.4.1. Overview
7.4.2. Biologics Market Forecast and Analysis
8. MYCOSIS FUNGOIDES THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL
8.1. OVERVIEW
8.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
8.3. HOSPITAL PHARMACIES
8.3.1. Overview
8.3.2. Hospital Pharmacies Market Forecast and Analysis
8.4. RETAIL PHARMACIES
8.4.1. Overview
8.4.2. Retail Pharmacies Market Forecast and Analysis
8.5. OTHERS
8.5.1. Overview
8.5.2. Others Market Forecast and Analysis
9. MYCOSIS FUNGOIDES THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Mycosis Fungoides Therapeutics Market Overview
9.1.2 North America Mycosis Fungoides Therapeutics Market Forecasts and Analysis
9.1.3 North America Mycosis Fungoides Therapeutics Market Forecasts and Analysis - By Type
9.1.4 North America Mycosis Fungoides Therapeutics Market Forecasts and Analysis - By Distribution Channel
9.1.5 North America Mycosis Fungoides Therapeutics Market Forecasts and Analysis - By Countries
9.1.5.1 United States Mycosis Fungoides Therapeutics Market
9.1.5.1.1 United States Mycosis Fungoides Therapeutics Market by Type
9.1.5.1.2 United States Mycosis Fungoides Therapeutics Market by Distribution Channel
9.1.5.2 Canada Mycosis Fungoides Therapeutics Market
9.1.5.2.1 Canada Mycosis Fungoides Therapeutics Market by Type
9.1.5.2.2 Canada Mycosis Fungoides Therapeutics Market by Distribution Channel
9.1.5.3 Mexico Mycosis Fungoides Therapeutics Market
9.1.5.3.1 Mexico Mycosis Fungoides Therapeutics Market by Type
9.1.5.3.2 Mexico Mycosis Fungoides Therapeutics Market by Distribution Channel
9.2. EUROPE
9.2.1 Europe Mycosis Fungoides Therapeutics Market Overview
9.2.2 Europe Mycosis Fungoides Therapeutics Market Forecasts and Analysis
9.2.3 Europe Mycosis Fungoides Therapeutics Market Forecasts and Analysis - By Type
9.2.4 Europe Mycosis Fungoides Therapeutics Market Forecasts and Analysis - By Distribution Channel
9.2.5 Europe Mycosis Fungoides Therapeutics Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Mycosis Fungoides Therapeutics Market
9.2.5.1.1 Germany Mycosis Fungoides Therapeutics Market by Type
9.2.5.1.2 Germany Mycosis Fungoides Therapeutics Market by Distribution Channel
9.2.5.2 France Mycosis Fungoides Therapeutics Market
9.2.5.2.1 France Mycosis Fungoides Therapeutics Market by Type
9.2.5.2.2 France Mycosis Fungoides Therapeutics Market by Distribution Channel
9.2.5.3 Italy Mycosis Fungoides Therapeutics Market
9.2.5.3.1 Italy Mycosis Fungoides Therapeutics Market by Type
9.2.5.3.2 Italy Mycosis Fungoides Therapeutics Market by Distribution Channel
9.2.5.4 Spain Mycosis Fungoides Therapeutics Market
9.2.5.4.1 Spain Mycosis Fungoides Therapeutics Market by Type
9.2.5.4.2 Spain Mycosis Fungoides Therapeutics Market by Distribution Channel
9.2.5.5 United Kingdom Mycosis Fungoides Therapeutics Market
9.2.5.5.1 United Kingdom Mycosis Fungoides Therapeutics Market by Type
9.2.5.5.2 United Kingdom Mycosis Fungoides Therapeutics Market by Distribution Channel
9.2.5.6 Rest of Europe Mycosis Fungoides Therapeutics Market
9.2.5.6.1 Rest of Europe Mycosis Fungoides Therapeutics Market by Type
9.2.5.6.2 Rest of Europe Mycosis Fungoides Therapeutics Market by Distribution Channel
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Mycosis Fungoides Therapeutics Market Overview
9.3.2 Asia-Pacific Mycosis Fungoides Therapeutics Market Forecasts and Analysis
9.3.3 Asia-Pacific Mycosis Fungoides Therapeutics Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Mycosis Fungoides Therapeutics Market Forecasts and Analysis - By Distribution Channel
9.3.5 Asia-Pacific Mycosis Fungoides Therapeutics Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Mycosis Fungoides Therapeutics Market
9.3.5.1.1 Australia Mycosis Fungoides Therapeutics Market by Type
9.3.5.1.2 Australia Mycosis Fungoides Therapeutics Market by Distribution Channel
9.3.5.2 China Mycosis Fungoides Therapeutics Market
9.3.5.2.1 China Mycosis Fungoides Therapeutics Market by Type
9.3.5.2.2 China Mycosis Fungoides Therapeutics Market by Distribution Channel
9.3.5.3 India Mycosis Fungoides Therapeutics Market
9.3.5.3.1 India Mycosis Fungoides Therapeutics Market by Type
9.3.5.3.2 India Mycosis Fungoides Therapeutics Market by Distribution Channel
9.3.5.4 Japan Mycosis Fungoides Therapeutics Market
9.3.5.4.1 Japan Mycosis Fungoides Therapeutics Market by Type
9.3.5.4.2 Japan Mycosis Fungoides Therapeutics Market by Distribution Channel
9.3.5.5 South Korea Mycosis Fungoides Therapeutics Market
9.3.5.5.1 South Korea Mycosis Fungoides Therapeutics Market by Type
9.3.5.5.2 South Korea Mycosis Fungoides Therapeutics Market by Distribution Channel
9.3.5.6 Rest of Asia-Pacific Mycosis Fungoides Therapeutics Market
9.3.5.6.1 Rest of Asia-Pacific Mycosis Fungoides Therapeutics Market by Type
9.3.5.6.2 Rest of Asia-Pacific Mycosis Fungoides Therapeutics Market by Distribution Channel
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Mycosis Fungoides Therapeutics Market Overview
9.4.2 Middle East and Africa Mycosis Fungoides Therapeutics Market Forecasts and Analysis
9.4.3 Middle East and Africa Mycosis Fungoides Therapeutics Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Mycosis Fungoides Therapeutics Market Forecasts and Analysis - By Distribution Channel
9.4.5 Middle East and Africa Mycosis Fungoides Therapeutics Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Mycosis Fungoides Therapeutics Market
9.4.5.1.1 South Africa Mycosis Fungoides Therapeutics Market by Type
9.4.5.1.2 South Africa Mycosis Fungoides Therapeutics Market by Distribution Channel
9.4.5.2 Saudi Arabia Mycosis Fungoides Therapeutics Market
9.4.5.2.1 Saudi Arabia Mycosis Fungoides Therapeutics Market by Type
9.4.5.2.2 Saudi Arabia Mycosis Fungoides Therapeutics Market by Distribution Channel
9.4.5.3 U.A.E Mycosis Fungoides Therapeutics Market
9.4.5.3.1 U.A.E Mycosis Fungoides Therapeutics Market by Type
9.4.5.3.2 U.A.E Mycosis Fungoides Therapeutics Market by Distribution Channel
9.4.5.4 Rest of Middle East and Africa Mycosis Fungoides Therapeutics Market
9.4.5.4.1 Rest of Middle East and Africa Mycosis Fungoides Therapeutics Market by Type
9.4.5.4.2 Rest of Middle East and Africa Mycosis Fungoides Therapeutics Market by Distribution Channel
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Mycosis Fungoides Therapeutics Market Overview
9.5.2 South and Central America Mycosis Fungoides Therapeutics Market Forecasts and Analysis
9.5.3 South and Central America Mycosis Fungoides Therapeutics Market Forecasts and Analysis - By Type
9.5.4 South and Central America Mycosis Fungoides Therapeutics Market Forecasts and Analysis - By Distribution Channel
9.5.5 South and Central America Mycosis Fungoides Therapeutics Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Mycosis Fungoides Therapeutics Market
9.5.5.1.1 Brazil Mycosis Fungoides Therapeutics Market by Type
9.5.5.1.2 Brazil Mycosis Fungoides Therapeutics Market by Distribution Channel
9.5.5.2 Argentina Mycosis Fungoides Therapeutics Market
9.5.5.2.1 Argentina Mycosis Fungoides Therapeutics Market by Type
9.5.5.2.2 Argentina Mycosis Fungoides Therapeutics Market by Distribution Channel
9.5.5.3 Rest of South and Central America Mycosis Fungoides Therapeutics Market
9.5.5.3.1 Rest of South and Central America Mycosis Fungoides Therapeutics Market by Type
9.5.5.3.2 Rest of South and Central America Mycosis Fungoides Therapeutics Market by Distribution Channel
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL MYCOSIS FUNGOIDES THERAPEUTICS MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. MYCOSIS FUNGOIDES THERAPEUTICS MARKET, KEY COMPANY PROFILES
12.1. AZURITY PHARMACEUTICALS, INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. TAKEDA PHARMACEUTICAL COMPANY LIMITED
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. SOLIGENIX
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. SEATTLE GENETICS, INC.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. MERCK AND CO., INC.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. KYOWA KIRIN CO., LTD.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. HORIZON THERAPEUTICS PLC
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. HELSINN HEALTHCARE SA
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. EISAI CO., LTD.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. CELGENE CORPORATION
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Azurity Pharmaceuticals, Inc.
2. Takeda Pharmaceutical Company Limited
3. Soligenix
4. Seattle Genetics, Inc.
5. Merck & Co., Inc.
6. Kyowa Kirin Co., Ltd.
7. Horizon Therapeutics plc
8. Helsinn Healthcare SA
9. Eisai Co., Ltd.
10. CELGENE CORPORATION

TIPRE00016770
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking